A detailed history of Vance Wealth, Inc. transactions in Medtronic PLC stock. As of the latest transaction made, Vance Wealth, Inc. holds 29,270 shares of MDT stock, worth $2.61 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares
29,270
Previous 55,670 47.42%
Holding current value
$2.61 Million
Previous $4.38 Million 39.85%
% of portfolio
1.0%
Previous 1.81%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$76.84 - $91.03 $2.03 Million - $2.4 Million
-26,400 Reduced 47.42%
29,270 $2.64 Million
Q2 2024

Aug 02, 2024

SELL
$78.71 - $87.02 $44,549 - $49,253
-566 Reduced 1.01%
55,670 $4.38 Million
Q1 2024

Apr 30, 2024

SELL
$82.84 - $88.09 $1.67 Million - $1.78 Million
-20,182 Reduced 26.41%
56,236 $4.9 Million
Q4 2023

Feb 05, 2024

BUY
$69.43 - $83.43 $1.35 Million - $1.62 Million
19,473 Added 34.2%
76,418 $6.3 Million
Q3 2023

Nov 03, 2023

SELL
$78.22 - $90.4 $230,983 - $266,951
-2,953 Reduced 4.93%
56,945 $4.46 Million
Q2 2023

Aug 02, 2023

SELL
$79.47 - $91.38 $213,933 - $245,994
-2,692 Reduced 4.3%
59,898 $5.28 Million
Q1 2023

May 10, 2023

SELL
$76.72 - $87.58 $19,793 - $22,595
-258 Reduced 0.41%
62,590 $5.05 Million
Q4 2022

Jan 27, 2023

BUY
$76.18 - $87.74 $4.1 Million - $4.73 Million
53,875 Added 600.41%
62,848 $0
Q3 2022

Oct 31, 2022

SELL
$80.75 - $95.31 $6,056 - $7,148
-75 Reduced 0.83%
8,973 $725,000
Q2 2022

Aug 09, 2022

SELL
$87.4 - $113.09 $156,970 - $203,109
-1,796 Reduced 16.56%
9,048 $812,000
Q1 2022

May 13, 2022

BUY
$100.58 - $112.38 $14,483 - $16,182
144 Added 1.35%
10,844 $1.2 Million
Q4 2021

Feb 18, 2022

BUY
$99.53 - $127.75 $1.06 Million - $1.37 Million
10,700 New
10,700 $1.11 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $119B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Vance Wealth, Inc. Portfolio

Follow Vance Wealth, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vance Wealth, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vance Wealth, Inc. with notifications on news.